The Cancer Center at the University of California, San Diego was granted NCI designation as a Clinical Cancer Center in 1979. It is currently composed of 209 Members drawn from 18 University departments and has a total peer-review funded income of $53.8 Million per annum (Direct Cost), of which $16.5 Million per annum is awarded by the NCI. An additional $13.2 Million per annum comes from non-peer reviewed sources. The Center conducts its collective research operations in over 120,000 sq ft of space, 53,919 sq ft of which are under the control of the Center Director. Center membership includes: One Nobel Laureate, seven members of the National Academy of Sciences, two members of the National Institute for Environmental Health Sciences, one member of the Advisory Council of the NCI, and a past-President of the American Association of Cancer Research. This application provides an updated progress report of seven Research Programs which reflect its scientific strengths and evolving interests, namely Cancer Biology, Cancer Genetics, Cancer Pharmacology, Cancer Prevention and Control, Cancer Symptom & Control, Translational Oncology and Viral Malignancy. It also consists of 12 shared resources, namely, Biostatistics, Clinical Trials Office/Protocol Review, Data Compilation & Analysis, Digital Imaging & Cell Microinjection, DNA Sequencing, Flow Cytometry, Histology & Immunohistochemistry, Microarray, Molecular Pathology, Nutrition, Radiation Medicine, and Transgenic Mouse. Our shared resources and programmatic alignments are designed to facilitate the flow of discoveries from the basic and prevention research groups to the clinical scientists in the Center. These investigators are organized in Specialized Cancer Units to facilitate the practical application of new discoveries. The Center is also specifically structured to encourage the counter flow of clinical observations and phenomena so that collaborative investigation by all research disciplines is stimulated. Translational oncology embodies the central philosophy of UCSD Cancer Center, which places the highest priority and emphasis on converting the discoveries from high quality research into tangible improvements in prevention, diagnosis, treatment and amelioration of discomfort for the benefit of the community.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA023100-21
Application #
6745134
Study Section
Subcommittee G - Education (NCI)
Program Officer
Shafik, Hasnaa
Project Start
1978-04-01
Project End
2006-04-30
Budget Start
2004-05-13
Budget End
2005-04-30
Support Year
21
Fiscal Year
2004
Total Cost
$4,065,117
Indirect Cost
Name
University of California San Diego
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Nguyen, Vi; Marmor, Rebecca A; Ramamoorthy, Sonia L et al. (2018) The Use of Solicited Publishing by Academic Surgeons. Surgery 164:212-218
Yan, Wei; Wu, Xiwei; Zhou, Weiying et al. (2018) Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol 20:597-609
Pandolfi, Erica C; Hoffmann, Hanne M; Schoeller, Erica L et al. (2018) Haploinsufficiency of SIX3 Abolishes Male Reproductive Behavior Through Disrupted Olfactory Development, and Impairs Female Fertility Through Disrupted GnRH Neuron Migration. Mol Neurobiol 55:8709-8727
Galanina, Natalie; Goodman, Aaron M; Cohen, Philip R et al. (2018) Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade. Cancer Immunol Res 6:1129-1135
Chin, Andrew R; Yan, Wei; Cao, Minghui et al. (2018) Polarized Secretion of Extracellular Vesicles by Mammary Epithelia. J Mammary Gland Biol Neoplasia 23:165-176
Garcia, Daniel A; Baek, Christina; Estrada, M Valeria et al. (2018) USP11 Enhances TGF?-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis. Mol Cancer Res 16:1172-1184
Jiang, Qingfei; Jamieson, Catriona (2018) BET'ing on Dual JAK/BET Inhibition as a Therapeutic Strategy for Myeloproliferative Neoplasms. Cancer Cell 33:3-5
Ramirez, Oscar; Aristizabal, Paula; Zaidi, Alia et al. (2018) Implementing a Childhood Cancer Outcomes Surveillance System Within a Population-Based Cancer Registry. J Glob Oncol :1-11
Liu, Liang; Yang, Lin; Yan, Wei et al. (2018) Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis. Clin Cancer Res 24:2370-2382
Lwin, Thinzar M; Murakami, Takashi; Miyake, Kentaro et al. (2018) Tumor-Specific Labeling of Pancreatic Cancer Using a Humanized Anti-CEA Antibody Conjugated to a Near-Infrared Fluorophore. Ann Surg Oncol 25:1079-1085

Showing the most recent 10 out of 862 publications